跳至主要内容
临床试验/NCT02677220
NCT02677220终止不适用

Implantation With the Nucleus CI532 Cochlear Implant in Adults

Cochlear1 个研究点 分布在 1 个国家目标入组 1 人开始时间: 2016年5月11日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
发起方
Cochlear
入组人数
1
试验地点
1
主要终点
AzBio Sentence Recognition in Noise

研究概览

简要总结

The aim of this study is to investigate the clinical benefit for patients implanted with the Nucleus® CI532 cochlear implant.

The Nucleus® CI532 has a pre-curved, perimodiolar array, the EA32, which is introduced into the cochlea through a straightening sheath.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Meet current cochlear implant criteria at the implanting center
  • 18 years or older with bilateral sensorineural hearing loss
  • Limited benefit from appropriate binaural hearing aids
  • Moderate to profound hearing loss in the low frequencies and profound hearing loss in the mid to high frequencies
  • Preoperative unaided threshold between 40 and 65 dB HL, inclusively, at 250 Hertz (Hz) and 500 Hz in the ear to be implanted
  • Fluent speaker in the language used to assess clinical performance

排除标准

  • Evidence of hearing loss prior to age 5
  • Sensorineural severe to profound hearing loss greater than 20 years at and above 2000Hz
  • Simultaneous bilateral implantation prior to the study
  • Medical or psychological conditions that contraindicate undergoing general anesthesia or surgery
  • Cochlear anomaly that might prevent complete insertion of the electrode array
  • Hearing impairment due to lesion or neuropathy of the acoustic nerve, VIII nerve, or central auditory pathway
  • Active middle ear infection
  • Tympanic membrane perforation
  • Unrealistic expectations
  • Unwillingness or inability co comply with all investigational requirements
  • Patients with existing cerebral shunts or drains
  • Recurrent episodes of bacterial meningitis

研究组 & 干预措施

Surgical

Experimental

Subjects to be implanted with the CI532 cochlear implant in one ear

干预措施: CI532 cochlear implant (Device)

结局指标

主要结局

AzBio Sentence Recognition in Noise

时间窗: 3 months post-activation

The AzBio Sentence test was recorded at 3 months prior to subject withdraw. Not collected at endpoint. AzBio Tests consists of 15 lists of 20 sentences each. AzBio sentences are spoken by different talkers in a conversational style with limited contextual cues that the listener can use to predict or 'fill in' unintelligible words. Each list includes 5 sentences from 4 different male and female speakers. Each word in the sentence counts toward the overall score and the resulting score is presented in percent correct.

次要结局

  • Speech, Spatial, and Qualities of Hearing Scale(6 months post-activation)
  • Glasgow Benefit Inventory(6 months post-activation)

研究者

发起方
Cochlear
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Implantation With the Nucleus CI532 Cochlear Implant... | 临床试验